If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Medical Affairs » Launch Optimization
Download FREE Excerpt
36 Info Graphics
27 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Pharmaceutical; Biotech; Biopharmaceutical; Chemical; Health Care; Diagnostic; Medical Device; Clinical Research; Laboratories
AbbVie; AcelRx; Alcon Laboratories; Alkermes; Alnylam Pharmaceuticals; AstraZeneca; Bausch Health; Boehringer Ingelheim; Celgene; cipla; Clovis Oncology; Crescendo Bioscience; Curis; Daiichi Sankyo; Dermira; Eisai; EMD Serono; Exelixis ; Fidia; GE Healthcare; Gedeon Richter ; GRAIL; Grifols; Imbrium Therapeutics; Lundbeck; Medacta; Merck; Merck KGaA; Merz Pharma; Novartis; Orchard Therapeutics; Roche; Sandoz; Sanofi Genzyme; Sanofi; Santen; Servier; Shire; Taiho Oncology; Takeda Pharmaceuticals; Torrent Pharmaceuticals Ltd.; Vertex Pharmaceuticals; Vifor Pharma; Zydus Cadila
Best Practices, LLC engaged over 60 Medical Affairs leaders from 44 pharmaceutical, biotechnology and medical device companies in this research study through a benchmarking survey, interviews and a roundtable discussion.
Key topics covered in this report include: